Nucleus-selective self-augmenting cascade nanoassemblies for targeted synergistic photo-chemo therapy of tumors.

Chem Commun (Camb)

Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China.

Published: September 2023

A nucleus-targeted enzyme prodrug nanocomposite, assembled from β-cyclodextrin-lysine (CL), catalase (CAT), Pt(IV) and chlorin e6 (Ce6), was developed for self-augmenting cascade photo-chemo therapy of tumors. It can effectively transport through the cytoplasm and accumulate in the nucleus, thereby significantly inhibiting tumor growth and lung metastasis.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d3cc03331gDOI Listing

Publication Analysis

Top Keywords

self-augmenting cascade
8
photo-chemo therapy
8
therapy tumors
8
nucleus-selective self-augmenting
4
cascade nanoassemblies
4
nanoassemblies targeted
4
targeted synergistic
4
synergistic photo-chemo
4
tumors nucleus-targeted
4
nucleus-targeted enzyme
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!